Infinium Pharmachem Limited (NSE:INFINIUM)
India · Delayed Price · Currency is INR 252.00
+4.25 (1.72%)
At close: Oct 15, 2025
Infinium Pharmachem Revenue
In the fiscal year ending March 31, 2025, Infinium Pharmachem had annual revenue of 1.56B INR with 14.78% growth. Infinium Pharmachem had revenue of 727.28M in the half year ending March 31, 2025, with 108.10% growth.
Revenue
1.56B
Revenue Growth
+14.78%
P/S Ratio
2.47
Revenue / Employee
10.81M
Employees
144
Market Cap
3.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.56B | 200.50M | 14.78% |
| Mar 31, 2024 | 1.36B | 214.34M | 18.76% |
| Mar 31, 2023 | 1.14B | 151.06M | 15.24% |
| Mar 31, 2022 | 991.19M | 443.60M | 81.01% |
| Mar 31, 2021 | 547.59M | 183.31M | 50.32% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,576.88B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Bajaj Finance | 387.76B |
| Infosys | 1,672.76B |